Johnson & Johnson
U.S. multinational manufacturer of pharmaceuticals and medical devices
JNJ NYSE
ISIN US4781601046 SEC CIK 200406 LEI 549300G0CFPGEF6X2043
Follow Johnson & Johnson
Weekly email: filings, results
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $94.2B | $26.8B |
| FY25 | $88.8B | $14.1B |
| FY24 | $85.2B | $35.2B |
| FY23 | $80B | $17.9B |
| FY22 | $78.7B | $20.9B |
| FY21 | $82.6B | $14.7B |
| FY20 | $82.1B | $15.1B |
| FY19 | $81.6B | $15.3B |
| FY18 | $76.5B | $1.3B |
| FY17 | $71.9B | $16.5B |
| FY16 | $70.1B | $15.4B |
| FY15 | $74.3B | $16.3B |
| FY14 | $71.3B | $13.8B |
| FY13 | $67.2B | $10.9B |
| FY12 | $65B | $9.7B |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 67.9% | - | 28.5% |
| FY25 | 69.1% | - | 15.8% |
| FY24 | 68.8% | - | 41.3% |
| FY23 | 69.3% | - | 22.4% |
| FY22 | 70.3% | - | 26.5% |
| FY21 | 65.6% | - | 17.8% |
| FY20 | 66.4% | - | 18.4% |
| FY19 | 66.8% | - | 18.8% |
| FY18 | 66.7% | - | 1.7% |
| FY17 | 69.7% | - | 23% |
| FY16 | 69.3% | - | 22% |
| FY15 | 69.4% | 29% | 22% |
| FY14 | 68.7% | 23% | 19.4% |
| FY13 | 67.8% | 22.2% | 16.1% |
| FY12 | 68.7% | 21.2% | 14.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | $19.7B |
| FY25 | $19.8B |
| FY24 | $18.2B |
| FY23 | $17.2B |
| FY22 | $19.8B |
| FY21 | $20.2B |
| FY20 | $19.9B |
| FY19 | $18.5B |
| FY18 | $17.8B |
| FY17 | $15.5B |
| FY16 | $16.1B |
| FY15 | $15B |
| FY14 | $13.8B |
| FY13 | $12.5B |
| FY12 | $11.4B |
Show the numbers
| Year | Buybacks |
|---|---|
| FY26 | $6B |
| FY25 | $2.4B |
| FY24 | $5.1B |
| FY23 | $6B |
| FY22 | $3.5B |
| FY21 | $3.2B |
| FY20 | $6.7B |
| FY19 | $5.9B |
| FY18 | $6.4B |
| FY17 | $9B |
| FY16 | $5.3B |
| FY15 | $7.1B |
| FY14 | $3.5B |
| FY13 | $12.9B |
| FY12 | $2.5B |
- Johnson & Johnson
- Healthcare median
Show the numbers
| Year | Johnson & Johnson | Healthcare median |
|---|---|---|
| FY26 | 28.5% | −11.1% |
| FY25 | 15.8% | −30.6% |
| FY24 | 41.3% | −47% |
| FY23 | 22.4% | −58% |
| FY22 | 26.5% | −80.4% |
| FY21 | 17.8% | −71.9% |
| FY20 | 18.4% | −62.2% |
| FY19 | 18.8% | −46.3% |
| FY18 | 1.7% | −49.6% |
| FY17 | 23% | −45.9% |
| FY16 | 22% | −36% |
| FY15 | 22% | −38.4% |
| FY14 | 19.4% | −35.5% |
| FY13 | 16.1% | −37.1% |
| FY12 | 14.9% | −29.1% |